Routes of
administration Oral CAS Number 101625-35-8 ChemSpider 33531 | ATC code none PubChem CID 36483 Molar mass 191.223 g/mol | |
 | ||
Legal status In general: uncontrolled | ||
6,7-Methylenedioxy-2-aminotetralin (MDAT) is a drug developed in the 1990s by a team at Purdue University led by David E. Nichols. It appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity. Hence, MDAT is considered likely to be a non-neurotoxic, putative entactogen in humans.
References
MDAT Wikipedia(Text) CC BY-SA